Evidence map›Paper›PMID 38497431›Full record

ArticleChild and adolescent mental health2024

Childhood attention-deficit hyperactivity disorder: socioeconomic inequalities in symptoms, impact, diagnosis and medication.

Anna Pearce, Paul Henery, S Vittal Katikireddi, Ruth Dundas, Alastair H Leyland, Dasha Nicholls, Russell M Viner, Lynda Fenton, Steven Hope

Open access · hybridAbstract read
In one paragraph

Article in Child and adolescent mental health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Anna PearceUniversity of Glasgow, Glasgow, UK.
Paul HeneryPublic Health Scotland, Edinburgh and Glasgow, UK.
S Vittal KatikireddiUniversity of Glasgow, Glasgow, UK.
Ruth DundasUniversity of Glasgow, Glasgow, UK.
Alastair H LeylandUniversity of Glasgow, Glasgow, UK.
Dasha NichollsImperial College London, London, UK.ORCID 0000-0001-7257-6605
Russell M VinerUniversity College London, London, UK.
Lynda FentonPublic Health Scotland, Edinburgh and Glasgow, UK.
Steven HopeUniversity College London, London, UK.ORCID 0000-0001-6759-6927
University of Glasgow · GBPublic Health Scotland · GBUniversity College London · GBImperial College London · GB

Funding

Medical Research Council MC_UU_00022/2Wellcome TrustWellcome Trust 205412/Z/16/Z
6 · The paper itself

Abstract

backgroundChildren from disadvantaged backgrounds are at greater risk of attention-deficit hyperactivity disorder (ADHD)-related symptoms, being diagnosed with ADHD, and being prescribed ADHD medications. We aimed to examine how inequalities manifest across the 'patient journey', from perceptions of impacts of ADHD symptoms on daily life, to the propensity to seek and receive a diagnosis and treatment.

methodsWe investigated four 'stages': (1) symptoms, (2) caregiver perception of impact, (3) diagnosis and (4) medication, in two data sets: UK Millennium Cohort Study (MCS, analytic n ~ 9,000), with relevant (parent-reported) information on all four stages (until 14 years); and a population-wide 'administrative cohort', which includes symptoms (child health checks) and prescriptions (dispensing records), born in Scotland, 2010-2012 (analytic n ~ 100,000), until ~6 years. We described inequalities according to maternal occupational status, with percentages and relative indices of inequality (RII).

resultsThe prevalence of ADHD symptoms and medication receipt was considerably higher in the least compared to the most advantaged children in the administrative cohort (RIIs of 5.9 [5.5-6.4] and 8.1 [4.2-15.6]) and the MCS (3.08 [2.68-3.55], 3.75 [2.21-6.36]). MCS analyses highlighted complexities between these two stages, however, those from least advantaged backgrounds, with ADHD symptoms, were the least likely to perceive impacts on daily life (15.7% vs. average 19.5%) and to progress from diagnosis to medication (44.1% vs. average 72.5%).

conclusionsDespite large inequalities in ADHD symptoms and medication, parents from the least advantaged backgrounds were less likely to report impacts of ADHD symptoms on daily life, and their children were less likely to have received medication postdiagnosis, highlighting how patient journeys differed according to socioeconomic circumstances.

Indexed as

Attention Deficit Disorder with HyperactivityChildCohort StudiesFamilyFemaleHumansParentsSocioeconomic FactorsADHDlarge datalifecourseSocial class

Identifiers

PMID38497431
PMCPMC11963976
OpenAlexW4392926636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.